Similar Articles
801 Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications
802 Differentiation of intrahepatic cholangiocarcinoma from hepatocellular carcinoma in high-risk patients: A predictive model using contrast-enhanced ultrasound
803 Conversion therapy and suitable timing for subsequent salvage surgery for initially unresectable hepatocellular carcinoma: What is new?
804 Expansion of the hepatocellular carcinoma Milan criteria in liver transplantation: Future directions
805 Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma
806 Proton therapy for hepatocellular carcinoma: Current knowledges and future perspectives
807 Multikinase inhibitor-associated hand-foot skin reaction as a predictor of outcomes in patients with hepatocellular carcinoma treated with sorafenib
808 Contemporary role of liver biopsy in hepatocellular carcinoma
809 Balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma
810 Role of microRNAs in the main molecular pathways of hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA